DVC, founded in 1998, has a total fund volume of 300 million Euro and has invested in approximately 70 companies. They invest in private companies with amounts ranging from 1 to 10 million Euro as a lead or co-lead investor. DVC's expertise in life sciences extends to therapeutic and diagnostic products, as well as platform and medical technologies. They have had notable investments in companies such as Panoratio, KeyNeurotek Pharmaceuticals, and MergeOptics.